Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Baricitinib drug can reduce mortality in patients with moderate to severe COVID-19

The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden.

16 Nov 2020

New Timestrip indicators to support the use of promising coronavirus vaccines

Timestrip®, the developer of smart indicator technology, has moved fast to develop a range of products that support use of the coronavirus vaccines now promising to become available.

16 Nov 2020

Primate model helps detect features of COVID-19 virus

Features of the SARS-CoV-2 virus causing COVID-19, which could be useful for developing vaccines and treatment strategies, were identified using a nonhuman primate model developed at the Korea Research Institute of Bioscience and Biotechnology (KRIBB).

16 Nov 2020

Study explains why anti-inflammatory drugs benefit only few people with severe COVID-19

The turning point for people with COVID-19 typically comes in the second week of symptoms. As most people begin to recover, a few others find it increasingly difficult to breathe and wind up in the hospital.

16 Nov 2020

Researchers use aerosolized molecules to shut down proteins generated by coronavirus

Researchers at Georgetown University Medical Center have successfully used molecules comprised of small strands of RNA to shut down the production of destructive proteins generated by the COVID-19 virus.

16 Nov 2020

PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro

A team of researchers from the Northern Arizona University evaluated a new PARP inhibitor, stenoparib, which has recently advanced to Stage II of clinical trials to treat ovarian cancer. Their study, an initial report on in vitro stenoparib activity against human coronaviruses such as SARS-CoV-2, has been published on the preprint server bioRxiv*.

15 Nov 2020

Strategizing pediatric healthcare preparedness for the second wave of the COVID-19 pandemic

The paper, put together by a team of scientists based in the United Kingdom and Italy, also underscored the need for healthcare policies to account for the very real possibility of inadequate protective personal equipment (PPE), staff and hospital capacity, aggravated by the increased number of pediatric infections.

15 Nov 2020

Study looks at SARS-CoV-2 RNA contamination in COVID-19 isolation ward of a hospital

To try and shed more light on SARS-CoV-2’s transmission, a research group based in Italy examined a COVID-19 isolation ward in a Milan hospital to evaluate the level of contamination present in the air and on surfaces with SARS-CoV-2 RNA (the virus’s genetic material).

15 Nov 2020

Promising new compounds to potentially treat novel coronaviruses identified

Researchers at the University of Maryland School of Medicine and School of Pharmacy have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19.

15 Nov 2020

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Scientists in Taiwan recently published a report on their use of anti-neutrophil strategies to treat acute respiratory distress syndrome (ARDS) – a life-threatening condition that can arise in critical COVID-19 cases – in the journal Frontiers in Pediatrics.

15 Nov 2020

Harnessing proteomics could improve therapeutic approaches to COVID-19

A research group in India has recently described how the field of proteomics could be pivotal in helping to tackle the current coronavirus disease 2019 (COVID-19) pandemic.

15 Nov 2020

Transmission of SARS-CoV-2 among US marine recruits after quarantine: A case study

A team of researchers at the Naval Medical Research Center, Silver Spring, USA, analyzed the risk of transmission of SARS-CoV-2 among marine recruits. Their study titled, “SARS-CoV-2 Transmission among Marine Recruits during Quarantine,” was published in the latest issue of the New England Journal of Medicine.

15 Nov 2020

MIT researchers unravel the molecular structure of key coronavirus protein

MIT chemists have determined the molecular structure of a protein found in the SARS-CoV-2 virus. This protein, called the envelope protein E, forms a cation-selective channel and plays a key role in the virus's ability to replicate itself and stimulate the host cell's inflammation response.

12 Nov 2020

Promising SARS-CoV-2 N epitope for more accurate diagnostic and surveillance antibody testing

A new study published on the preprint server bioRxiv in November 2020 describes the virus's N protein as a promising epitope for serology.

12 Nov 2020

SARS-CoV-2-induces temporary loss of smell in mice

Now, a new study published on the preprint server bioRxiv in November 2020 presents the onset of olfactory dysfunction (loss of smell) in mice infected with the virus, examining this process at the cellular level. In doing so, this study throws more light on this curious symptom and COVID-19’s manifestations outside the lungs.

12 Nov 2020

Modeling suggests lower COVID-19 cases in Lombardy's second wave

Researchers found a negative association between the number of excess deaths during the first wave of the epidemic and the number of second-wave cases. This could be because of both a sort of herd immunity and changes in behavioral response.

12 Nov 2020

Researchers assess risks posed by SARS-CoV-2 to Antarctica wildlife

Researchers have assessed risks posed by the ongoing COVID-19 pandemic on Antarctica wildlife.

12 Nov 2020

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.

12 Nov 2020

KHN’s ‘What the Health?’: Transition interrupted

Five days after the election was called for President-elect Joe Biden, President Donald Trump has not conceded — and instead ordered his administration not to begin the transition of power.

12 Nov 2020

Time to discuss potentially unpleasant side effects of COVID shots? Scientists say yes.

Drugmaker Pfizer is expected to seek federal permission to release its COVID-19 vaccine by the end of November, a move that holds promise for quelling the pandemic, but also sets up a tight time frame for making sure consumers understand what it will mean to actually get the shots.

12 Nov 2020

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Baricitinib drug can reduce mortality in patients with moderate to severe COVID-19

New Timestrip indicators to support the use of promising coronavirus vaccines

Primate model helps detect features of COVID-19 virus

Study explains why anti-inflammatory drugs benefit only few people with severe COVID-19

Researchers use aerosolized molecules to shut down proteins generated by coronavirus

PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro

Strategizing pediatric healthcare preparedness for the second wave of the COVID-19 pandemic

Study looks at SARS-CoV-2 RNA contamination in COVID-19 isolation ward of a hospital

Promising new compounds to potentially treat novel coronaviruses identified

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Harnessing proteomics could improve therapeutic approaches to COVID-19

Transmission of SARS-CoV-2 among US marine recruits after quarantine: A case study

MIT researchers unravel the molecular structure of key coronavirus protein

Promising SARS-CoV-2 N epitope for more accurate diagnostic and surveillance antibody testing

SARS-CoV-2-induces temporary loss of smell in mice

Modeling suggests lower COVID-19 cases in Lombardy's second wave

Researchers assess risks posed by SARS-CoV-2 to Antarctica wildlife

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

KHN’s ‘What the Health?’: Transition interrupted

Time to discuss potentially unpleasant side effects of COVID shots? Scientists say yes.

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in